Left ventricular function recovery after revascularization: comparative effects of percutaneous coronary intervention and coronary artery bypass grafting
- PMID: 30169342
- DOI: 10.1097/HCO.0000000000000566
Left ventricular function recovery after revascularization: comparative effects of percutaneous coronary intervention and coronary artery bypass grafting
Abstract
Purpose of review: In 2013, heart failure with recovered ejection fraction (HFrecEF) was introduced as a new heart failure phenotype. This review provides an overview of HFrecEF and the comparative effects of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) on left ventricular ejection fraction (LVEF) recovery in patients with ischemic cardiomyopathy.
Recent findings: There has been emerging data indicating that LV functional recovery is possible and HFrecEF is associated with improved survival and better quality of life. CABG may be associated with larger improvement in LVEF when compared with PCI. However, there is significant paucity of studies, which directly compare the impact of PCI and CABG on LVEF recovery in the setting of ischemic cardiomyopathy.
Summary: LVEF recovery is emerging as an important outcome with demonstrated survival and quality-of-life benefits. Future randomized clinical trials comparing the impact of contemporary PCI and CABG on LVEF recovery are needed in patients with ischemic cardiomyopathy.
Similar articles
-
Myocardial work in patients with heart failure and ischemic cardiomyopathy according to the mode of coronary revascularization.Hellenic J Cardiol. 2024 Jul-Aug;78:16-24. doi: 10.1016/j.hjc.2023.08.005. Epub 2023 Aug 15. Hellenic J Cardiol. 2024. PMID: 37586481
-
Outcomes after percutaneous coronary intervention or bypass surgery for ischemic cardiomyopathy.Rev Esp Cardiol (Engl Ed). 2025 Jun;78(6):533-541. doi: 10.1016/j.rec.2024.11.003. Epub 2024 Nov 19. Rev Esp Cardiol (Engl Ed). 2025. PMID: 39566819 English, Spanish.
-
Does the extended use of arterial grafts compromise the myocardial recovery after coronary artery bypass grafting in left ventricular dysfunction?Eur J Cardiothorac Surg. 1998 Oct;14(4):353-9. doi: 10.1016/s1010-7940(98)00219-x. Eur J Cardiothorac Surg. 1998. PMID: 9845138
-
Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction.Curr Cardiol Rep. 2024 May;26(5):435-442. doi: 10.1007/s11886-024-02045-2. Epub 2024 Apr 20. Curr Cardiol Rep. 2024. PMID: 38642298 Free PMC article. Review.
-
Heart failure with recovered ejection fraction.J Echocardiogr. 2019 Mar;17(1):5-9. doi: 10.1007/s12574-018-0396-2. Epub 2018 Sep 14. J Echocardiogr. 2019. PMID: 30218436 Review.
Cited by
-
Impact of Allopurinol Pretreatment on Coronary Blood Flow and Revascularization Outcomes after Percutaneous Coronary Intervention in Acute STEMI Patients: A Randomized Double Blind Clinical Trial.ARYA Atheroscler. 2023 Nov-Dec;19(6):1-9. doi: 10.48305/arya.2023.11577.2121. ARYA Atheroscler. 2023. PMID: 38883850 Free PMC article.
-
Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.Clin Cardiol. 2022 Feb;45(2):152-161. doi: 10.1002/clc.23779. Epub 2022 Jan 25. Clin Cardiol. 2022. PMID: 35077580 Free PMC article. Review.
-
Ginsenoside Rg2 alleviates myocardial fibrosis by regulating TGF-β1/Smad signalling pathway.Pharm Biol. 2021 Dec;59(1):106-113. doi: 10.1080/13880209.2020.1867197. Pharm Biol. 2021. PMID: 33535854 Free PMC article.
-
Myocardial Viability Testing in the Management of Ischemic Heart Failure.Life (Basel). 2022 Nov 1;12(11):1760. doi: 10.3390/life12111760. Life (Basel). 2022. PMID: 36362914 Free PMC article. Review.
-
Clinical predictors of improvement in left ventricular ejection fraction in U.S. veterans with heart failure.Am Heart J Plus. 2022 Jul 22;19:100183. doi: 10.1016/j.ahjo.2022.100183. eCollection 2022 Jul. Am Heart J Plus. 2022. PMID: 38558863 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous